Literature DB >> 10802271

Low-dose oral contraceptives and bone mineral density: an evidence-based analysis.

W Kuohung1, L Borgatta, P Stubblefield.   

Abstract

We reviewed studies of the association of oral contraceptive (OC) use and bone mineral density (BMD). We limited the review to studies of women using low-dose oral contraceptives and that measured BMD by bone densitometry. A total of 13 studies met the inclusion criteria. Nine of these showed a positive effect of OC use on BMD, and four did not show an association. However, none of the studies showed a decrease in BMD with OC use. We classified the level of evidence from each study according to the guidelines of the US Preventive Services Task Force. The level of evidence supporting a positive association between OC use and increased BMD is II-1. There is fair evidence (Category B) to support the position that OC use has a favorable effect on BMD. We made suggestions for a study design that could yield Level I evidence.

Entities:  

Keywords:  Americas; Biology; Contraception; Contraceptive Methods; Developed Countries; Family Planning; Literature Review; North America; Northern America; Oral Contraceptives; Oral Contraceptives, Low-dose; Physiology; Skeletal Effects--women; United States; Women

Mesh:

Substances:

Year:  2000        PMID: 10802271     DOI: 10.1016/s0010-7824(00)00086-x

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  14 in total

Review 1.  Noncontraceptive health benefits of oral contraceptives.

Authors:  Andrew M Kaunitz
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

Review 2.  Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review.

Authors:  S L Liu; C M Lebrun
Journal:  Br J Sports Med       Date:  2006-01       Impact factor: 13.800

3.  Oral contraceptive use and fracture risk-a retrospective study of 12,970 women in the UK.

Authors:  S Dombrowski; L Jacob; P Hadji; K Kostev
Journal:  Osteoporos Int       Date:  2017-04-13       Impact factor: 4.507

Review 4.  Premenopausal women and low bone density.

Authors:  Aliya Khan
Journal:  Can Fam Physician       Date:  2006-06       Impact factor: 3.275

5.  The effect of oral contraceptive different patterns of use on circulating IGF-1 and bone mineral density in healthy premenopausal women.

Authors:  Amany Y Elkazaz; Khaled Salama
Journal:  Endocrine       Date:  2014-05-27       Impact factor: 3.633

Review 6.  Current pharmacological options for the management of primary hyperparathyroidism.

Authors:  Peter Vestergaard
Journal:  Drugs       Date:  2006       Impact factor: 9.546

7.  The effect of past use of oral contraceptive on bone mineral density, bone biochemical markers and muscle strength in healthy pre and post menopausal women.

Authors:  Fadoua Allali; Laila El Mansouri; Fatima zohra Abourazzak; Linda Ichchou; Hamza Khazzani; Loubna Bennani; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  BMC Womens Health       Date:  2009-11-03       Impact factor: 2.809

Review 8.  Hormonal contraception in adolescents: special considerations.

Authors:  Rollyn M Ornstein; Martin M Fisher
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

9.  Comparison of Two Different Injectable Contraceptive Methods: Depo-medroxy Progesterone Acetate (DMPA) and Cyclofem.

Authors:  Firoozeh Veisi; Maryam Zangeneh
Journal:  J Family Reprod Health       Date:  2013-09

Review 10.  Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update.

Authors:  Emily S Mohn; Hua J Kern; Edward Saltzman; Susan H Mitmesser; Diane L McKay
Journal:  Pharmaceutics       Date:  2018-03-20       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.